Cross Linking Reagents; LC-SMCC (Succinimidyl-4-[N-Maleimidomethyl]cyclohexane-1-carboxy-[6-amidocaproate]); Pierce; NHS ester, reacts with primary amines; Maleimide reacts with sulfhydryls; Cyclohexane bridge adds stability; 50mg
-
P/N:
PI22362
- UOM: EA
- UOM Qty: 1
|
|
Protein Modification; Methyl PEG8-NHS Esters; Pierce; Unique pegylation reagent has discrete spacer of 8 PEG groups; Discrete molecular weights for consistency of performance in protein-modification applications; 100mg
-
P/N:
PI22509
- UOM: EA
- UOM Qty: 1
|
|
Protein Modification; Methyl-PEG12-NHS Esters; Pierce; Unique pegylation reagent has discrete spacer of 12 PEG groups; Discrete molecular weights for consistency of performance in protein-modification applications; 100mg
-
P/N:
PI22685
- UOM: EA
- UOM Qty: 1
|
|
Protein Modification; Methyl-PEG12-Maleimide; Pierce; Discrete molecular weight for consistent performance; 12 ethylene oxide units in spacer; Reactive groups maleimide allows site-specific targeting of -SH groups on proteins; 100mg
-
P/N:
PI22711
- UOM: EA
- UOM Qty: 1
|
|
Protein Modification; SAT(PEG4); Pierce; Protein-modification reagent with defined PEG chain length; Reactive group NHS ester, reacts with primary amines at pH 7.0-9.0; Spacer consists of 4 ethylene oxide subunits
-
P/N:
PI26099
- UOM: EA
- UOM Qty: 1
|
|
-
P/N:
PI31007
- UOM: EA
- UOM Qty: 1
|
|
Ligand Building Block, Succinimidyl Ester (O2) Ligand; HaloTag; 5mg; Reacts with any reporter group, protein, or nucleic acid derivative containing an amine, forming stable amide bond linkages
-
P/N:
PRP1691
- UOM: EA
- UOM Qty: 1
|
|
Ligand Building Block, Amine (O2) Ligand; HaloTag; 5mg; Reacts with any reporter group, protein, or nucleic acid derivative containing an activated carboxylic acid, sulfonyl halide, or isocyanate
-
P/N:
PRP6711
- UOM: EA
- UOM Qty: 1
|
|
HALOTAG AMINE (04) LIGAND 5MG
-
P/N:
PAP6741
- UOM: EA
- UOM Qty: 1
|
|
HALOTAG SUCCINIMIDYL ESTER 5MG
-
P/N:
PAP6751
- UOM: EA
- UOM Qty: 1
|
|